Cerus Corporation (CERS)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 1.6400 |
| Open | 1.6300 |
| Bid | 1.6700 x 100 |
| Ask | 1.7200 x 500 |
| Day's Range | 1.6150 - 1.6900 |
| 52 Week Range | 1.2100 - 3.0800 |
| Volume | |
| Avg. Volume | 1,627,639 |
| Market Cap | 304.555M |
| Beta (5Y Monthly) | 1.30 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Cerus Corporation (NASDAQ:CERS) is a favorite amongst institutional investors who own 64%
Key Insights Significantly high institutional ownership implies Cerus' stock price is sensitive to their trading...
- GuruFocus.com
Insider Sell: President and CEO William Greenman Sells 125,926 Shares of Cerus Corp (CERS)
On March 14, 2024, William Greenman, President and Chief Executive Officer of Cerus Corp (NASDAQ:CERS), sold 125,926 shares of the company, according to a recent SEC Filing.
- GuruFocus.com
Insider Sell: COO Vivek Jayaraman Sells 53,041 Shares of Cerus Corp (CERS)
Cerus Corp (NASDAQ:CERS), a company specializing in the field of blood transfusion safety with its innovative INTERCEPT Blood System, has reported an insider transaction involving its Chief Operating Officer, Vivek Jayaraman.
© 2024 Yahoo. All rights reserved.